These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2372776)
1. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinomas. Ohshio G; Shimada Y; Manabe T; Tobe T Cancer; 1990 May; 65(9):2102. PubMed ID: 2372776 [No Abstract] [Full Text] [Related]
2. Derivation and assay of biological effects of monoclonal antibodies to epidermal growth factor receptors. Sato JD; Le AD; Kawamoto T Methods Enzymol; 1987; 146():63-81. PubMed ID: 3500387 [No Abstract] [Full Text] [Related]
3. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer. Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526 [TBL] [Abstract][Full Text] [Related]
4. Purification of functionally active epidermal growth factor receptor protein using a competitive antagonist monoclonal antibody and competitive elution with epidermal growth factor. Gill GN; Weber W Methods Enzymol; 1987; 146():82-8. PubMed ID: 3500388 [No Abstract] [Full Text] [Related]
5. Affinity purification of active epidermal growth factor receptor using monoclonal antibodies. Hsuan J; Yaish P Methods Enzymol; 1991; 200():378-88. PubMed ID: 1659659 [No Abstract] [Full Text] [Related]
6. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Berchuck A; Rodriguez GC; Kamel A; Dodge RK; Soper JT; Clarke-Pearson DL; Bast RC Am J Obstet Gynecol; 1991 Feb; 164(2):669-74. PubMed ID: 1992720 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma. Sugiyama K; Yonemura Y; Miyazaki I Cancer; 1989 Apr; 63(8):1557-61. PubMed ID: 2647276 [TBL] [Abstract][Full Text] [Related]
8. Effect of human epidermal growth factor on cell growth and its receptor in human gastric carcinoma cell lines. Ochiai A; Takanashi A; Takekura N; Yoshida K; Miyamori S; Harada T; Tahara E Jpn J Clin Oncol; 1988 Mar; 18(1):15-25. PubMed ID: 3258388 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function. Kawamoto T; Sato GH; Takahashi K; Nishi M; Taniguchi S; Sato JD Cytotechnology; 1990 May; 3(3):279-93. PubMed ID: 1366662 [No Abstract] [Full Text] [Related]
10. Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. Sakai K; Mori S; Kawamoto T; Taniguchi S; Kobori O; Morioka Y; Kuroki T; Kano K J Natl Cancer Inst; 1986 Nov; 77(5):1047-52. PubMed ID: 3464796 [TBL] [Abstract][Full Text] [Related]
11. The efficient production of monoclonal antibodies to the epidermal growth factor receptor. King I; Sartorelli AC J Immunol Methods; 1987 Oct; 103(1):153-4. PubMed ID: 2443577 [No Abstract] [Full Text] [Related]
12. Los receptores epidérmicos humanos en el cáncer gástrico: alteraciones moleculares y su papel como diana terapéutica. Bustos-Carpinteyro AR; Magaña-Torres MT; González-García JR; Torres-Jasso JH; Sánchez-López JY Gac Med Mex; 2017; 153(7):830-840. PubMed ID: 29414960 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma. Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025 [TBL] [Abstract][Full Text] [Related]
14. Growth factor receptor monoclonal antibodies and cancer immunotherapy. Sato GH; Sato JD J Natl Cancer Inst; 1989 Nov; 81(21):1600-1. PubMed ID: 2795686 [No Abstract] [Full Text] [Related]
15. Gastric carcinoma, epidermal growth factor, and epidermal growth factor receptor. Lee EY; Wang TC; Clouse RE; DeSchryver-Kecskemeti K Gastroenterology; 1991 Jan; 100(1):289. PubMed ID: 2006930 [No Abstract] [Full Text] [Related]
16. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194 [TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemistry using epidermal growth factor receptor mutation-specific antibodies of delE746-A750 and L858R in lung adenocarcinomas]. Fan XS; Liu B; Yu B; Shi SS; Wang X; Zhang J; Wang JD; Lu ZF; Ma HH; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):173-7. PubMed ID: 23769436 [TBL] [Abstract][Full Text] [Related]
18. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468. Modjtahedi H; Styles JM; Dean CJ Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290 [TBL] [Abstract][Full Text] [Related]
19. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas. Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth. Harwerth IM; Wels W; Schlegel J; Müller M; Hynes NE Br J Cancer; 1993 Dec; 68(6):1140-5. PubMed ID: 7903153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]